Joseph V. Pergolizzi

Dr. Pergolizzi is the co-founder of NEMA Research, Inc., a specialty Contract Research Organization; he is also a former subcommittee member of the FDA’s Safe Use Initiative for Analgesics, and chairman of PAINWEEK and Consultant to National Pain Foundation Board of Directors. Dr. Pergolizzi is the former director of business development and financial affairs for the Johns Hopkins University School of Medicine Clinical Trials Unit. Dr. Pergolizzi is a top development and regulatory consultant for blockbuster-branded analgesics, such as Nucynta, Cymbalta and Butrans.